Glaxosmithkline Pharmaceuticals Ltd.

•
₹ 2,902.2-3.25%

2026-08-21

gsk-india.comBSE: 500660NSE: GLAXO
Market Cap₹ 51,399 Cr.
Current Price₹ 3,000
High / Low₹ 3,055 / 2,088
Stock P/E48.1
Book Value₹ 149
Price to Book16.94
Dividend Yield1.88 %
ROCE66.8 %
ROE48.8 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Company has delivered good profit growth of 29.2% CAGR over last 5 years
  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 60.3%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 43.9%
  • Company has consistently been profitable over the last 5 years
  • Operating margins have improved to 31.0% from 25.4%

CONS

  • Stock is trading at 16.9x its book value
  • Recurring exceptional / one-off items are inflating headline profit
  • Company has delivered a poor sales growth of 5.5% over past five years
  • Growth is decelerating - 3Y profit CAGR (19.5%) trails the 5Y trend (29.2%)
  • Expensive relative to growth - PEG of 2.5

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.113620.702139.4220263.101191.0018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.GLAXO3034.0548.1251398.641.88237.1815.69938.4416.5566.7931.49
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023
762
618
Operating Profit
—
OPM %
—
Other Income
36
Interest
0
Depreciation
16
181
Tax %
26.93%
Net Profit
0
8
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
957
668
Operating Profit
—
OPM %
—
Other Income
28
Interest
0
Depreciation
18
299
Tax %
27.29%
Net Profit
0
13
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
805
587
Operating Profit
—
OPM %
—
Other Income
28
Interest
0
Depreciation
17
65
Tax %
30.12%
Net Profit
0
3
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
930
673
Operating Profit
—
OPM %
—
Other Income
30
Interest
1
Depreciation
18
271
Tax %
28.14%
Net Profit
0
11
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
815
584
Operating Profit
—
OPM %
—
Other Income
36
Interest
0
Depreciation
16
249
Tax %
26.89%
Net Profit
182
11
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
1,011
689
Operating Profit
—
OPM %
—
Other Income
35
Interest
0
Depreciation
17
344
Tax %
26.56%
Net Profit
252
15
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
949
658
Operating Profit
—
OPM %
—
Other Income
35
Interest
0
Depreciation
19
308
Tax %
25.39%
Net Profit
230
14
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
974
641
Operating Profit
—
OPM %
—
Other Income
41
Interest
1
Depreciation
15
359
Tax %
26.69%
Net Profit
263
16
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
805
554
Operating Profit
—
OPM %
—
Other Income
44
Interest
0
Depreciation
16
279
Tax %
26.51%
Net Profit
205
12
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
980
644
Operating Profit
—
OPM %
—
Other Income
34
Interest
1
Depreciation
17
354
Tax %
27.26%
Net Profit
257
15
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
1,041
670
Operating Profit
—
OPM %
—
Other Income
32
Interest
1
Depreciation
20
400
Tax %
26.08%
Net Profit
296
17
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
995
644
Operating Profit
—
OPM %
—
Other Income
36
Interest
1
Depreciation
13
373
Tax %
25.53%
Net Profit
278
16
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
938
660
Operating Profit
—
OPM %
—
Other Income
44
Interest
1
Depreciation
16
322
Tax %
26.44%
Net Profit
237
1
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
169
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
2,908
2,489
Operating Profit
492
OPM %
17
Other Income
73
Interest
0
Depreciation
26
511
Tax %
34
Net Profit
337
EPS
40
Dividend Payout %
75
Minority Interest
0
Share of Associates
0
Adjusted EPS
20
Minority Interest
0
Share of Associates
0
Adjusted EPS
20
Mar 2018
2,871
2,366
Operating Profit
560
OPM %
20
Other Income
55
Interest
0
Depreciation
38
540
Tax %
35
Net Profit
351
EPS
21
Dividend Payout %
85
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Mar 2019
3,128
2,527
Operating Profit
703
OPM %
22
Other Income
102
Interest
1
Depreciation
49
683
Tax %
35
Net Profit
445
EPS
26
Dividend Payout %
76
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Mar 2020
3,224
2,567
Operating Profit
736
OPM %
23
Other Income
79
Interest
6
Depreciation
83
306
Tax %
70
Net Profit
93
EPS
6
Dividend Payout %
727
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2021
2,926
2,327
Operating Profit
709
OPM %
24
Other Income
111
Interest
4
Depreciation
79
454
Tax %
37
Net Profit
287
EPS
21
Dividend Payout %
142
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Mar 2022
3,278
2,516
Operating Profit
838
OPM %
26
Other Income
76
Interest
2
Depreciation
68
779
Tax %
51
Net Profit
381
EPS
100
Dividend Payout %
90
Minority Interest
0
Share of Associates
0
Adjusted EPS
100
Minority Interest
0
Share of Associates
0
Adjusted EPS
100
Mar 2023
3,252
2,447
Operating Profit
905
OPM %
28
Other Income
101
Interest
2
Depreciation
66
836
Tax %
27
Net Profit
608
EPS
36
Dividend Payout %
89
Minority Interest
0
Share of Associates
0
Adjusted EPS
36
Minority Interest
0
Share of Associates
0
Adjusted EPS
36
Mar 2024
3,454
2,545
Operating Profit
1,031
OPM %
30
Other Income
123
Interest
2
Depreciation
70
816
Tax %
28
Net Profit
590
EPS
35
Dividend Payout %
92
Minority Interest
0
Share of Associates
0
Adjusted EPS
35
Minority Interest
0
Share of Associates
0
Adjusted EPS
35
Mar 2025
3,749
2,572
Operating Profit
1,323
OPM %
35
Other Income
146
Interest
1
Depreciation
67
1,260
Tax %
26
Net Profit
928
EPS
55
Dividend Payout %
99
Minority Interest
0
Share of Associates
0
Adjusted EPS
55
Minority Interest
0
Share of Associates
0
Adjusted EPS
55
Mar 2026
3,822
2,512
Operating Profit
1,455
OPM %
38
Other Income
145
Interest
3
Depreciation
66
1,406
Tax %
26
Net Profit
1,036
EPS
61
Dividend Payout %
93
Minority Interest
0
Share of Associates
0
Adjusted EPS
61
Minority Interest
0
Share of Associates
0
Adjusted EPS
61
TTM
3,955
2,618
Operating Profit
—
OPM %
—
Other Income
145
Interest
3
Depreciation
67
1,449
Tax %
26
Net Profit
1,068
EPS
—
Dividend Payout %
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
3%
5 Years:
5%
3 Years:
6%

COMPOUNDED PROFIT GROWTH

10 Years:
11%
5 Years:
24%
3 Years:
19%

STOCK PRICE CAGR

10 Years:
7%
5 Years:
14%
3 Years:
29%
1 Year:
8%

RETURN ON EQUITY

10 Years:
25%
5 Years:
36%
3 Years:
44%
Last Year:
49%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2018

Sep 11

1:1

Bonus issue Inter alia, 1. Mr. Marc Jones, Non-Executive Director and Mr. Rajeshwar R. Bajaaj, Independent Director have ceased to be a Directors of the Company from close of the business hours on 24th July 2018. 2. Bonus Issue The Board considered, approved and recommended a bonus issue of one equity share for every equity share held as on a record date to be determined. The bonus issue of equity shares will be subject to approval by the shareholders, and any other applicable statutory and regulatory approvals. The Bonus shares once allotted shall rank pari-passu in all respects and carry the same rights as the existing Equity Shares and shall be entitled to participate in full in any dividend and other corporate action, recommended and declared after the new equity shares are allotted

Mar 2017
Equity Capital
85
1,922
Trade Payables
279
4,302
Total Liabilities
6,588
253
Capital Work in Progress
573
0
426
0
Cash & Bank
900
4,436
Total Assets
6,588
Total Debt
2
Net Working Capital
952
Contingent Liabilities
697
Book Value per Share
236.93
Face Value
10.00
Total Debt
2
Net Working Capital
952
Contingent Liabilities
697
Book Value per Share
236.93
Face Value
10.00
Mar 2018
Equity Capital
85
1,973
Trade Payables
506
5,076
Total Liabilities
7,639
323
Capital Work in Progress
923
0
500
0
Cash & Bank
1,296
4,596
Total Assets
7,639
Total Debt
1
Net Working Capital
582
Contingent Liabilities
503
Book Value per Share
242.89
Face Value
10.00
Total Debt
1
Net Working Capital
582
Contingent Liabilities
503
Book Value per Share
242.89
Face Value
10.00
Mar 2019
Equity Capital
169
1,970
Trade Payables
406
5,259
Total Liabilities
7,804
430
Capital Work in Progress
1,003
0
486
0
Cash & Bank
1,171
4,714
Total Assets
7,804
Total Debt
1
Net Working Capital
552
Contingent Liabilities
534
Book Value per Share
126.31
Face Value
10.00
Total Debt
1
Net Working Capital
552
Contingent Liabilities
534
Book Value per Share
126.31
Face Value
10.00
Mar 2020
Equity Capital
169
1,651
Trade Payables
357
845
Total Liabilities
3,023
757
Capital Work in Progress
120
0
483
0
Cash & Bank
1,083
580
Total Assets
3,023
Total Debt
0
Net Working Capital
753
Contingent Liabilities
477
Book Value per Share
107.47
Face Value
10.00
Total Debt
0
Net Working Capital
753
Contingent Liabilities
477
Book Value per Share
107.47
Face Value
10.00
Mar 2021
Equity Capital
169
1,309
Trade Payables
466
1,067
Total Liabilities
3,012
386
Capital Work in Progress
13
0
547
0
Cash & Bank
1,158
908
Total Assets
3,012
Total Debt
0
Net Working Capital
668
Contingent Liabilities
491
Book Value per Share
87.26
Face Value
10.00
Total Debt
0
Net Working Capital
668
Contingent Liabilities
491
Book Value per Share
87.26
Face Value
10.00
Mar 2022
Equity Capital
169
2,494
Trade Payables
579
1,278
Total Liabilities
4,520
329
Capital Work in Progress
31
366
535
0
Cash & Bank
2,485
775
Total Assets
4,520
Total Debt
0
Net Working Capital
2,009
Contingent Liabilities
355
Book Value per Share
157.19
Face Value
10.00
Total Debt
0
Net Working Capital
2,009
Contingent Liabilities
355
Book Value per Share
157.19
Face Value
10.00
Mar 2023
Equity Capital
169
1,574
Trade Payables
428
1,022
Total Liabilities
3,193
329
Capital Work in Progress
20
518
460
0
Cash & Bank
1,156
710
Total Assets
3,193
Total Debt
0
Net Working Capital
1,168
Contingent Liabilities
354
Book Value per Share
102.89
Face Value
10.00
Total Debt
0
Net Working Capital
1,168
Contingent Liabilities
354
Book Value per Share
102.89
Face Value
10.00
Mar 2024
Equity Capital
169
1,617
Trade Payables
625
998
Total Liabilities
3,410
320
Capital Work in Progress
14
813
525
222
Cash & Bank
1,063
452
Total Assets
3,410
Total Debt
0
Net Working Capital
1,273
Contingent Liabilities
387
Book Value per Share
105.47
Face Value
10.00
Total Debt
0
Net Working Capital
1,273
Contingent Liabilities
387
Book Value per Share
105.47
Face Value
10.00
Mar 2025
Equity Capital
169
1,797
Trade Payables
708
1,293
Total Liabilities
3,967
283
Capital Work in Progress
14
1,118
482
293
Cash & Bank
1,404
374
Total Assets
3,967
Total Debt
0
Net Working Capital
1,505
Contingent Liabilities
456
Book Value per Share
116.06
Face Value
10.00
Total Debt
0
Net Working Capital
1,505
Contingent Liabilities
456
Book Value per Share
116.06
Face Value
10.00
Mar 2026
Equity Capital
169
2,114
Trade Payables
570
1,337
Total Liabilities
4,190
280
Capital Work in Progress
33
1,392
458
273
Cash & Bank
1,391
364
Total Assets
4,190
Total Debt
0
Net Working Capital
1,827
Contingent Liabilities
515
Book Value per Share
134.77
Face Value
10.00
Total Debt
0
Net Working Capital
1,827
Contingent Liabilities
515
Book Value per Share
134.77
Face Value
10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
234
Cash from Investing
301
Cash from Financing
-511
24
Free Cash Flow
-142
OCF / Net Profit
0.70
Cumulative 5-Year FCF
0
OCF / Net Profit
0.70
Cumulative 5-Year FCF
0
Mar 2018
473
Cash from Investing
-104
Cash from Financing
-307
62
Free Cash Flow
16
OCF / Net Profit
1.35
Cumulative 5-Year FCF
0
OCF / Net Profit
1.35
Cumulative 5-Year FCF
0
Mar 2019
409
Cash from Investing
-153
Cash from Financing
-358
-102
Free Cash Flow
177
OCF / Net Profit
0.92
Cumulative 5-Year FCF
0
OCF / Net Profit
0.92
Cumulative 5-Year FCF
0
Mar 2020
490
Cash from Investing
-57
Cash from Financing
-428
6
Free Cash Flow
480
OCF / Net Profit
5.26
Cumulative 5-Year FCF
0
OCF / Net Profit
5.26
Cumulative 5-Year FCF
0
Mar 2021
578
Cash from Investing
418
Cash from Financing
-696
300
Free Cash Flow
578
OCF / Net Profit
2.01
Cumulative 5-Year FCF
1,109
OCF / Net Profit
2.01
Cumulative 5-Year FCF
1,109
Mar 2022
811
Cash from Investing
-406
Cash from Financing
-524
-119
Free Cash Flow
802
OCF / Net Profit
2.13
Cumulative 5-Year FCF
2,053
OCF / Net Profit
2.13
Cumulative 5-Year FCF
2,053
Mar 2023
484
Cash from Investing
808
Cash from Financing
-1,543
-251
Free Cash Flow
452
OCF / Net Profit
0.80
Cumulative 5-Year FCF
2,489
OCF / Net Profit
0.80
Cumulative 5-Year FCF
2,489
Mar 2024
582
Cash from Investing
9
Cash from Financing
-561
29
Free Cash Flow
559
OCF / Net Profit
0.99
Cumulative 5-Year FCF
2,871
OCF / Net Profit
0.99
Cumulative 5-Year FCF
2,871
Mar 2025
1,290
Cash from Investing
-46
Cash from Financing
-769
475
Free Cash Flow
1,286
OCF / Net Profit
1.39
Cumulative 5-Year FCF
3,678
OCF / Net Profit
1.39
Cumulative 5-Year FCF
3,678
Mar 2026
903
Cash from Investing
397
Cash from Financing
-737
563
Free Cash Flow
835
OCF / Net Profit
0.87
Cumulative 5-Year FCF
3,935
OCF / Net Profit
0.87
Cumulative 5-Year FCF
3,935

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
EPS (₹)
39.76
Book Value (₹)
236.93
Dividend per Share (₹)
30.00
Cash EPS (₹)
21.44
Operating Margin %
16.40%
Net Margin %
11.23%
ROE %
16.08%
ROCE %
24.39%
5.16%
Debtor Days
18
Inventory Days
58
Payable Days
79
-3
Debt to Equity (x)
0.00x
Interest Coverage (x)
2045.74x
2.08x
Revenue Growth %
2.49%
Operating Profit Growth %
-18.19%
Net Profit Growth %
-10.46%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
41.41
Book Value (₹)
242.89
Dividend per Share (₹)
35.00
Cash EPS (₹)
22.95
Operating Margin %
18.56%
Net Margin %
11.62%
ROE %
17.26%
ROCE %
26.56%
4.93%
Debtor Days
19
Inventory Days
56
Payable Days
115
-40
Debt to Equity (x)
0.00x
Interest Coverage (x)
2856.45x
1.20x
Revenue Growth %
-1.27%
Operating Profit Growth %
13.88%
Net Profit Growth %
4.13%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
26.29
Book Value (₹)
126.31
Dividend per Share (₹)
20.00
Cash EPS (₹)
29.16
Operating Margin %
22.48%
Net Margin %
14.24%
ROE %
21.22%
ROCE %
32.54%
5.77%
Debtor Days
16
Inventory Days
58
Payable Days
123
-49
Debt to Equity (x)
0.00x
Interest Coverage (x)
1232.59x
1.20x
Revenue Growth %
8.94%
Operating Profit Growth %
25.48%
Net Profit Growth %
26.99%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
5.50
Book Value (₹)
107.47
Dividend per Share (₹)
40.00
Cash EPS (₹)
10.38
Operating Margin %
21.90%
Net Margin %
2.77%
ROE %
4.71%
ROCE %
15.76%
1.72%
Debtor Days
12
Inventory Days
53
Payable Days
106
-42
Debt to Equity (x)
0.00x
Interest Coverage (x)
49.26x
1.74x
Revenue Growth %
3.08%
Operating Profit Growth %
4.71%
Net Profit Growth %
-79.07%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
21.14
Book Value (₹)
87.26
Dividend per Share (₹)
30.00
Cash EPS (₹)
21.60
Operating Margin %
22.68%
Net Margin %
9.19%
ROE %
17.42%
ROCE %
27.74%
9.52%
Debtor Days
18
Inventory Days
60
Payable Days
120
-41
Debt to Equity (x)
0.00x
Interest Coverage (x)
129.56x
1.49x
Revenue Growth %
-9.27%
Operating Profit Growth %
-3.74%
Net Profit Growth %
208.21%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
100.04
Book Value (₹)
157.19
Dividend per Share (₹)
90.00
Cash EPS (₹)
26.50
Operating Margin %
23.30%
Net Margin %
10.59%
ROE %
18.39%
ROCE %
37.72%
10.11%
Debtor Days
21
Inventory Days
55
Payable Days
141
-64
Debt to Equity (x)
0.00x
Interest Coverage (x)
391.29x
2.18x
Revenue Growth %
12.05%
Operating Profit Growth %
18.19%
Net Profit Growth %
32.55%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
36.05
Book Value (₹)
102.89
Dividend per Share (₹)
32.00
Cash EPS (₹)
39.75
Operating Margin %
25.36%
Net Margin %
17.03%
ROE %
27.58%
ROCE %
38.06%
15.76%
Debtor Days
20
Inventory Days
51
Payable Days
143
-72
Debt to Equity (x)
0.00x
Interest Coverage (x)
462.54x
1.88x
Revenue Growth %
-0.80%
Operating Profit Growth %
8.03%
Net Profit Growth %
59.58%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
34.83
Book Value (₹)
105.47
Dividend per Share (₹)
32.00
Cash EPS (₹)
38.94
Operating Margin %
24.01%
Net Margin %
15.59%
ROE %
33.43%
ROCE %
46.49%
17.87%
Debtor Days
20
Inventory Days
47
Payable Days
144
-77
Debt to Equity (x)
0.00x
Interest Coverage (x)
454.77x
1.84x
Revenue Growth %
6.21%
Operating Profit Growth %
13.96%
Net Profit Growth %
-2.91%
-3.39%
P/E (x)
55.80x
P/B (x)
18.42x
Dividend Yield %
1.65%
30.89x
Mar 2025
EPS (₹)
54.76
Book Value (₹)
116.06
Dividend per Share (₹)
54.00
Cash EPS (₹)
58.70
Operating Margin %
28.56%
Net Margin %
22.50%
ROE %
49.43%
ROCE %
67.64%
25.15%
Debtor Days
23
Inventory Days
45
Payable Days
175
-108
Debt to Equity (x)
0.00x
Interest Coverage (x)
960.03x
1.79x
Revenue Growth %
8.56%
Operating Profit Growth %
28.32%
Net Profit Growth %
57.23%
57.23%
P/E (x)
52.55x
P/B (x)
24.79x
Dividend Yield %
1.88%
35.77x
Mar 2026
EPS (₹)
61.15
Book Value (₹)
134.77
Dividend per Share (₹)
57.00
Cash EPS (₹)
65.08
Operating Margin %
31.01%
Net Margin %
24.54%
ROE %
48.76%
ROCE %
66.79%
25.40%
Debtor Days
24
Inventory Days
41
Payable Days
173
-108
Debt to Equity (x)
0.00x
Interest Coverage (x)
515.59x
2.03x
Revenue Growth %
1.93%
Operating Profit Growth %
9.92%
Net Profit Growth %
11.69%
11.69%
P/E (x)
37.34x
P/B (x)
16.94x
Dividend Yield %
2.50%
25.64x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
75.00
4.02
7.50
Government
0.00
13.48
Sep 2024
75.00
4.36
7.34
Government
0.00
13.30
Dec 2024
75.00
4.50
7.30
Government
0.00
13.19
Mar 2025
75.00
4.52
7.79
Government
0.00
12.69
Jun 2025
75.00
4.89
7.71
Government
0.00
12.41
Sep 2025
75.00
4.80
7.76
Government
0.00
12.45
Dec 2025
75.00
4.63
7.70
Government
0.00
12.66
Mar 2026
75.00
4.62
7.68
Government
0.00
12.70
Jun 2026
75.00
4.79
7.81
Government
0.00
12.41

Documents

Announcements

  • General Updates

    2026-08-19 - GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates

  • Copy of Newspaper Publication

    2026-08-14 - GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls